Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480520 | SCV000571284 | uncertain significance | not provided | 2022-02-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not located in the triple helical region, where the majority of pathogenic missense variants occur (Symoens et al., 2012; HGMD); This variant is associated with the following publications: (PMID: 22696272) |
Labcorp Genetics |
RCV001333205 | SCV001394362 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-06-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001333205 | SCV001525722 | uncertain significance | Ehlers-Danlos syndrome, classic type, 1 | 2018-09-21 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Prevention |
RCV003431044 | SCV004117926 | uncertain significance | COL5A1-related disorder | 2023-04-24 | criteria provided, single submitter | clinical testing | The COL5A1 c.5311G>A variant is predicted to result in the amino acid substitution p.Asp1771Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0050% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-137726991-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |